Trial Profile
A Phase I Dose Escalation Study to Assess the Pharmacokinetics (PK) of FDL169 in Healthy Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs FDL 169 (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- Sponsors Flatley Discovery Lab
- 29 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2016 New trial record